Your browser is no longer supported. Please, upgrade your browser.
Settings
SPRB Spruce Biosciences, Inc. daily Stock Chart
SPRB [NASD]
Spruce Biosciences, Inc.
Index- P/E- EPS (ttm)-0.78 Insider Own21.50% Shs Outstand21.06M Perf Week18.50%
Market Cap419.52M Forward P/E- EPS next Y- Insider Trans75.64% Shs Float0.26M Perf Month-
Income-17.30M PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Sales- P/S- EPS this Y-32.80% Inst Trans- Short Ratio- Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh1.74 P/C11.46 EPS next 5Y- ROE- 52W Range15.12 - 20.05 Perf YTD17.18%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High9.30% Beta-
Dividend %- Quick Ratio6.10 Sales past 5Y- Gross Margin- 52W Low44.94% ATR1.70
Employees15 Current Ratio6.10 Sales Q/Q- Oper. Margin- RSI (14)- Volatility9.52% -
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.17 Prev Close19.92
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume339.80K Price21.92
Recom- SMA2026.43% SMA5026.43% SMA20026.43% Volume52,487 Change10.02%
Oct-16-20 07:38PM  
Oct-14-20 04:05PM  
Oct-09-20 03:49PM  
01:28PM  
11:51AM  
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novo Holdings A/S10% OwnerOct 14Buy15.00250,0003,750,0004,989,336Oct 16 04:49 PM
RiverVest Venture Fund III, L.10% OwnerOct 14Buy15.00250,0003,750,0002,148,281Oct 16 12:34 PM
Muralidhar BaliDirectorOct 14Buy15.00200,0003,000,0001,792,518Oct 16 12:24 PM
O'Donnell NiallDirectorOct 14Buy15.00250,0003,750,000695,905Oct 16 12:21 PM
Chaya Moghrabi DinaDirectorOct 14Buy15.00250,0003,750,0002,161,022Oct 16 12:14 PM
Omega Fund VI, L.P.Former 10% OwnerOct 14Buy15.00250,0003,750,0002,161,022Oct 16 12:15 PM
HANSSON JONASDirectorOct 14Buy15.00250,0003,750,0002,033,621Oct 16 12:07 PM
HealthCap VIII, L.P.Former 10% OwnerOct 14Buy15.00250,0003,750,0002,033,621Oct 16 12:08 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.